Distinct gene programs underpinning disease tolerance and resistance in influenza virus infection.
disease tolerance
immune defense strategies
influenza A virus
molecular signatures
resistance
Journal
Cell systems
ISSN: 2405-4720
Titre abrégé: Cell Syst
Pays: United States
ID NLM: 101656080
Informations de publication
Date de publication:
21 12 2022
21 12 2022
Historique:
received:
21
03
2022
revised:
30
08
2022
accepted:
16
11
2022
pubmed:
15
12
2022
medline:
27
12
2022
entrez:
14
12
2022
Statut:
ppublish
Résumé
When challenged with an invading pathogen, the host-defense response is engaged to eliminate the pathogen (resistance) and to maintain health in the presence of the pathogen (disease tolerance). However, the identification of distinct molecular programs underpinning disease tolerance and resistance remained obscure. We exploited transcriptional and physiological monitoring across 33 mouse strains, during in vivo influenza virus infection, to identify two host-defense gene programs-one is associated with hallmarks of disease tolerance and the other with hallmarks of resistance. Both programs constitute generic responses in multiple mouse and human cell types. Our study describes the organizational principles of these programs and validates Arhgdia as a regulator of disease-tolerance states in epithelial cells. We further reveal that the baseline disease-tolerance state in peritoneal macrophages is associated with the pathophysiological response to injury and infection. Our framework provides a paradigm for the understanding of disease tolerance and resistance at the molecular level.
Identifiants
pubmed: 36516834
pii: S2405-4712(22)00463-X
doi: 10.1016/j.cels.2022.11.004
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1002-1015.e9Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests Tel Aviv University has filed a patent application on markers of resistance and disease tolerance and uses thereof with I.G.-V., E.B., O.C., G.Y., and N.P.-Y. as inventors (PCT/IL2022/050880), which has been filed in the Israel PCT Receiving Office.